Point-of-care testing for CXCL13 in Lyme neuroborreliosis

Cerebrospinal fluid CXCL13 is a marker for Lyme neuroborreliosis (LNB). CXCL13 lateral flow immunoassay (LFA) was compared to CXCL13 ELISA. CXCL13 LFA results correlated strongly with CXCL13 ELISA results. CXCL13 LFA is a rapid and easy to perform test, which is suitable for routine point-of-care diagnostics of suspected LNB patients.
Source: Diagnostic Microbiology and Infectious Disease - Category: Microbiology Authors: Tags: Note Source Type: research